PO-1623 Use of OSLDs for dosimetric verification of Helical TomoTherapy dynamic field width treatment plans. (August 2021) - Prountzos, N.; Pantelis, E.; Papagiannis, P.; Karaiskos, P.; Moutsatsos, A.; Pappas, E.; Fotos, N.; Kanellopoulou, S.